Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.25
(
-1.79%
)
Bitcoin
75,399.99
(
-0.59%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 100052

Monday, 12/06/2010 3:45:32 AM

Monday, December 06, 2010 3:45:32 AM

Post# of 257644
Brilinta’s European brand name is Brilique (which sounds like something to clean a barbeque grill):

http://www.astrazeneca.com/Media/Press-releases/Article/European-Commission-Approves-Brilique

The drug received rubber-stamp approval from the EU Commission today for prevention of thrombosis in patients with ACS; it had been endorsed by the CHMP on 9/24/10.

In the US, the PDUFA date for Brilinta is 12/16/10; an FDA advisory panel backed approval by a 7-1 vote on 7/28/10 (#msg-52749102).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today